Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderly [0.03%]
老年人静脉血栓栓塞症的风险评估及预防治疗
F Couturaud,K Lacut,C Leroyer et al.
F Couturaud et al.
Numerous large randomized controlled trials have assessed the benefit of prophylactic anticoagulation for venous thromboembolism in selected patients. However, few trials were conducted in elderly patients, as this issue was not addressed i...
Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients [0.03%]
外科手术患者静脉血栓栓塞症的风险评估和预防措施的疗效评估研究进展
David Bergqvist
David Bergqvist
This review article first deals with risk factors for developing postoperative venous thromboembolism. The various pharmacological prophylactic methods available today are summarized with focus on dominating method low molecular weight hepa...
Cecilia Becattini,Giancarlo Agnelli
Cecilia Becattini
Risk factors of recurrent venous thromboembolism: the role of residual vein thrombosis [0.03%]
复发性静脉血栓栓塞的危险因素：残余静脉血栓的作用
Paolo Prandoni
Paolo Prandoni
In 313 consecutive symptomatic outpatients with proximal deep vein thrombosis (DVT) who had a conventional anticoagulation, an ultrasound assessment of the common femoral and the popliteal vein was performed three months after the acute epi...
Is hyperhomocysteinemia an important risk factor of cardiovascular disease? [0.03%]
高同型半胱氨酸血症是心血管疾病的危险因素吗？
Marco Cattaneo
Marco Cattaneo
Homocysteine, vitamin B6 and the risk of recurrent venous thromboembolism [0.03%]
同型半胱氨酸、维生素B6与复发性静脉血栓栓塞的风险关系
Sabine Eichinger
Sabine Eichinger
Hyperhomocysteinemia (HHC) is an independent risk factor for cardiovascular disease, and even mildly to moderately elevated homocysteine levels have been associated with a heightened risk for a first and recurrent venous thromboembolism (VT...
Gene-gene and gene-environment interactions in mild hyperhomocysteinemia [0.03%]
轻度高同型半胱氨酸血症的基因-基因和基因-环境交互作用
Armando D&#x;Angelo,Giuseppina Mazzola,Isabella Fermo
Armando D&#x;Angelo
Mild/moderate hyperhomocysteinemia (HHcy), a highly prevalent condition, is independently associated with an increased risk of arterial and venous thromboembolic diseases. Early reports of the association of mild/moderate HHcy with juvenile...
Management of patients with acute venous thromboembolism: findings from the RIETE registry [0.03%]
急性静脉血栓栓塞患者的治疗：来自RIETE注册研究的结果
Manuel Monreal,Carmen Suárez,José A G Fajardo et al.
Manuel Monreal et al.
Guidelines for the treatment of venous thromboembolism (VTE) are mainly based on randomized controlled trials, but a number of patients with VTE are excluded from trials due to co-morbidities (i.e., recent bleeding, renal insufficiency, thr...
Sabine Eichinger
Sabine Eichinger
During pregnancy, elevated markers of coagulation and fibrinolytic system activation, such as D-Dimer, indicate increased thrombin activity and increased fibrinolysis following fibrin formation. Testing for D-Dimer during pregnancy could th...
M Nijkeuter,M V Huisman
M Nijkeuter
Diagnosing pulmonary embolism is problematic since clinical signs and symptoms of PE are aspecific. Diagnostic algorithms have been developed to rationalize the use of imaging tests in patients with a clinical suspicion of PE. An algorithm ...